Supernus Pharmaceuticals Stock Price and Value Analysis

Should you buy Supernus Pharmaceuticals stock? (NasdaqGM:SUPN). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is not making money.
  • This company is less known than others.
  • This company pays no dividend.

Inside the SUPN Numbers

SUPN Price
(Supernus Pharmaceuticals stock price per share)
$44.80
[?] PE Ratio versus Sector 111% higher than other Healthcare stocks
[?] PE Ratio versus Industry 64% lower than other Unknown stocks
[?] Free Cash Flow Jitter 0%

Is Supernus Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Supernus Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy SUPN Stock?

Does Supernus Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.